The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Giampaolo Tortora

Department of Endocrinology and Molecular and Clinical Oncology

University of Naples Federico II

Naples

Italy

[email]@unina.it

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Endocrinology and Molecular and Clinical Oncology, University of Naples Federico II, Naples, Italy. 2000 - 2008
  • Division of Medical Oncology, Department of Molecular and Clinical Endocrinology and Oncology, Università di Napoli "Federico II, " 80131 Napoli, Italy. 2003 - 2004

References

  1. Combined targeting of EGFR-dependent and VEGF-dependent pathways: rationale, preclinical studies and clinical applications. Tortora, G., Ciardiello, F., Gasparini, G. Nature Clinical Practice. Oncology (2008) [Pubmed]
  2. The rationale for the combination of selective EGFR inhibitors with cytotoxic drugs and radiotherapy. Tortora, G., Gelardi, T., Ciardiello, F., Bianco, R. Int. J. Biol. Markers (2007) [Pubmed]
  3. Angiogenesis: a target for cancer therapy. Tortora, G., Melisi, D., Ciardiello, F. Curr. Pharm. Des. (2004) [Pubmed]
  4. Combined targeted inhibition of bcl-2, bcl-XL, epidermal growth factor receptor, and protein kinase A type I causes potent antitumor, apoptotic, and antiangiogenic activity. Tortora, G., Caputo, R., Damiano, V., Caputo, R., Troiani, T., Veneziani, B.M., De Placido, S., Bianco, A.R., Zangemeister-Wittke, U., Ciardiello, F. Clin. Cancer Res. (2003) [Pubmed]
  5. Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. Tortora, G., Caputo, R., Damiano, V., Melisi, D., Bianco, R., Fontanini, G., Veneziani, B.M., De Placido, S., Bianco, A.R., Ciardiello, F. Clin. Cancer Res. (2003) [Pubmed]
  6. Antisense targeting protein kinase A type I as a drug for integrated strategies of cancer therapy. Tortora, G., Ciardiello, F. Ann. N. Y. Acad. Sci. (2003) [Pubmed]
  7. Preclinical and phase I study of oxaliplatin and topotecan in combination in human cancer. Tortora, G., Ciardiello, F., Damiano, V., De Laurentiis, M., Matano, E., Pepe, S., Pensabene, M., Catalano, G., De Placido, S., Bianco, A.R. Ann. Oncol. (2002) [Pubmed]
  8. Protein kinase A as target for novel integrated strategies of cancer therapy. Tortora, G., Ciardiello, F. Ann. N. Y. Acad. Sci. (2002) [Pubmed]
  9. Combined blockade of protein kinase A and bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis. Tortora, G., Caputo, R., Damiano, V., Bianco, R., Fontanini, G., Cuccato, S., De Placido, S., Bianco, A.R., Ciardiello, F. Clin. Cancer Res. (2001) [Pubmed]
  10. Oral administration of a novel taxane, an antisense oligonucleotide targeting protein kinase A, and the epidermal growth factor receptor inhibitor Iressa causes cooperative antitumor and antiangiogenic activity. Tortora, G., Caputo, R., Damiano, V., Fontanini, G., Melisi, D., Veneziani, B.M., Zunino, F., Bianco, A.R., Ciardiello, F. Clin. Cancer Res. (2001) [Pubmed]
  11. Oral antisense that targets protein kinase A cooperates with taxol and inhibits tumor growth, angiogenesis, and growth factor production. Tortora, G., Bianco, R., Damiano, V., Fontanini, G., De Placido, S., Bianco, A.R., Ciardiello, F. Clin. Cancer Res. (2000) [Pubmed]
  12. Targeting of epidermal growth factor receptor and protein kinase A: molecular basis and therapeutic applications. Tortora, G., Ciardiello, F. Ann. Oncol. (2000) [Pubmed]
  13. A novel MDM2 anti-sense oligonucleotide has anti-tumor activity and potentiates cytotoxic drugs acting by different mechanisms in human colon cancer. Tortora, G., Caputo, R., Damiano, V., Bianco, R., Chen, J., Agrawal, S., Bianco, A.R., Ciardiello, F. Int. J. Cancer (2000) [Pubmed]
 
WikiGenes - Universities